AMENDMENT AGREEMENT TO PURCHASE AGREEMENTAgreement to Purchase Agreement • March 15th, 2006 • Avant Immunotherapeutics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 15th, 2006 Company Industry JurisdictionTHIS AMENDMENT AGREEMENT TO PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of March 14, 2006 between AVANT Immunotherapeutics, Inc., a Delaware corporation (“AVANT”), and PRF Vaccine Holdings LLC, a Delaware limited liability company (“PRF”), an Affiliate of Paul Royalty Fund II, L.P., a Delaware limited partnership.